Blue Bell Private Wealth Management, LLC Crispr Therapeutics Ag Transaction History
Blue Bell Private Wealth Management, LLC
- $500 Million
- Q4 2024
A detailed history of Blue Bell Private Wealth Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Blue Bell Private Wealth Management, LLC holds 207 shares of CRSP stock, worth $9,091. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207
Previous 207
-0.0%
Holding current value
$9,091
Previous $9,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CRSP
# of Institutions
486Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$394 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$384 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$167 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$122 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$121 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.43B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....